Publications by authors named "Giovanni Argiroffi"

Claim this Profile
C
Correction to: The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro‑entero‑pancreatic neuroendocrine tumours (GEP NETs) patients treated with [177Lu] Lu‑DOTATATE.
Marco Maccauro, Mariarosaria Cuomo, Matteo Bauckneht, Matteo Bagnalasta, Stefania Mazzaglia, Giovanni Argiroffi

Eur J Nucl Med Mol Imaging· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro-entero-pancreatic neuroendocrine tumours (GEP NETs) patients treated with [Lu]Lu-DOTATATE.
Marco Maccauro, Mariarosaria Cuomo, Matteo Bauckneht, Matteo Bagnalasta, Stefania Mazzaglia, Giovanni Argiroffi

Eur J Nucl Med Mol Imaging· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cylindrical TGR as early radiological predictor of RLT progression in GEPNETs: a proof of concept.
Federica Scalorbi, Enrico Matteo Garanzini, Giuseppina Calareso, Chiara Marzi, Gabriella Di Rocco, Giovanni Argiroffi

Sci Rep· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Deauville score and quantitative positron emission tomography parameters as a predictive tool of anti-CD19 chimeric antigen receptor T-cell efficacy.
Anna Guidetti, Anna Dodero, Alice Lorenzoni, Sara Pizzamiglio, Giovanni Argiroffi

Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Application of FLIC model to predict adverse events onset in neuroendocrine tumors treated with PRRT.
Federica Scalorbi, Giovanni Argiroffi, Michela Baccini, Luca Gherardini, Valentina Fuoco

Sci Rep· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on radioligand therapy with Lu-PSMA for metastatic castration-resistant prostate cancer: clinical aspects and survival effects.
Valentina Fuoco, Giovanni Argiroffi, Stefania Mazzaglia, Alice Lorenzoni, Valentina Guadalupi

Tumori· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioembolization of Hepatocellular Carcinoma with Y Glass Microspheres: No Advantage of Voxel Dosimetry with Respect to Mean Dose in Dose-Response Analysis with Two Radiological Methods.
Chiara Romanò, Stefania Mazzaglia, Marco Maccauro, Carlo Spreafico, Alejandro Gabutti, Giovanni Argiroffi

Cancers (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of FLIC model to predict adverse events onset in neuroendocrine tumors treated with PRRT.
Federica Scalorbi, Giovanni Argiroffi, Michela Baccini, Luca Gherardini, Valentina Fuoco

Sci Rep· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the COVID-19 pandemic in nuclear medicine departments: preliminary report of the first international survey.
Salvatore Annunziata, Matteo Bauckneht, Domenico Albano, Giovanni Argiroffi, Diletta Calabrò

Eur J Nucl Med Mol Imaging· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F-Facbc in Prostate Cancer: A Systematic Review and Meta-Analysis.
Riccardo Laudicella, Domenico Albano, Pierpaolo Alongi, Giovanni Argiroffi, Matteo Bauckneht

Cancers (Basel)· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Theragnostic Use of Radiolabelled Dota-Peptides in Meningioma: From Clinical Demand to Future Applications.
Riccardo Laudicella, Domenico Albano, Salvatore Annunziata, Diletta Calabrò, Giovanni Argiroffi

Cancers (Basel)· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis